Clinical trial

Thyroid Treatment Trial

NCT00348413 · Singapore National Eye Centre, Other · Completed

Key facts

NCT number NCT00348413
Title Thyroid Treatment Trial
Official title Comparison of Efficacy and Safety of Intravenous Pulsed Methylprednisolone and Oral Methotrexate Versus Intravenous Pulsed Methylprednisolone and Oral Placebo in the Treatment of Active Moderate and Severe Thyroid Eye Disease - a Prospective, Randomized, Double-blind, Parallel, Controlled…
Lead sponsor Singapore National Eye Centre, Other
Collaborators International Stem Cell Forum
Status Completed
Study type Interventional
Conditions Graves Ophthalmopathy
Intervention type Drug
Interventions Intravenous Methylprednisolone + Oral Methotrexate vs Intravenous Methylprednisolone + Placebo
Enrollment 80
Start date Jun 1, 2003
Primary completion Jul 1, 2008
Completion Jul 1, 2008
First posted Jul 4, 2006
Last update posted May 12, 2010
Countries Singapore

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies